RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

From a pharma industry point of view, he played the molecular cards he had. And the cards weren't as good as I, and many others, thought they were. Did he oversell the hand? Well, if one is trying to get a partner or investors to buy in, you sell the most positive view you ethically can. I'm not aware, in retrospect, of any overt dishonesty on the part of Cortex management. Spin, yes, that's part of their job.

It's the biggest loss of my investing career, by far. But in my view, that's on me. I'm not looking for a scapegoat. There's no strategic alternative path that clearly would have been better, with all due respect to Alzheimer's.

P.S. There was a November 8 timeline mentioned, but I didnt read it carefully--you're probably right that it was contingent upon exercise.

NP